Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Maintaining laboratory quality assurance and safety in a pandemic: Experiences from the KEMRI-Wellcome Trust Research Programme laboratory’s COVID-19 response
Journal article
Gumba H. et al, (2021), Wellcome Open Research, 6, 205 - 205
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
Journal article
Ndwiga L. et al, (2021), International Journal for Parasitology: Drugs and Drug Resistance, 16, 155 - 161
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data
Journal article
Ojal J. et al, (2021), Wellcome Open Research, 6, 127 - 127
Spatial-temporal clustering of malaria using routinely collected health facility data on the Kenyan Coast.
Journal article
Kamau A. et al, (2021), Malaria journal, 20
Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision
Journal article
Watson JA. et al, (2021)
Impact of Plasmodium falciparum small-sized extracellular vesicles on host peripheral blood mononuclear cells
Journal article
Mwangi SJ. et al, (2021), Wellcome Open Research, 5, 197 - 197
10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity
Journal article
Addy JWG. et al, (2021), Wellcome Open Research, 6, 79 - 79
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
Journal article
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42
Endemic chikungunya fever in Kenyan children: a prospective cohort study.
Journal article
Nyamwaya DK. et al, (2021), BMC infectious diseases, 21
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.
Journal article
Sutton HJ. et al, (2021), Cell Rep, 34
Individual-level variations in malaria susceptibility and acquisition of clinical protection
Journal article
Valletta JJ. et al, (2021), Wellcome Open Research, 6, 22 - 22
Evaluating the Performance of Malaria Genetics for Inferring Changes in Transmission Intensity Using Transmission Modeling
Journal article
Watson OJ. et al, (2021), Molecular Biology and Evolution, 38, 274 - 289
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Journal article
Juan-Giner A. et al, (2021), Lancet (London, England), 397, 119 - 127
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
Journal article
Uyoga S. et al, (2021), Science (New York, N.Y.), 371, 79 - 82
Author Correction: Investigating the drivers of the spatio-temporal patterns of genetic differences between Plasmodium falciparum malaria infections in Kilifi County, Kenya.
Journal article
Malinga J. et al, (2020), Scientific reports, 10
A systematic review of changing malaria disease burden in sub-Saharan Africa since 2000: comparing model predictions and empirical observations
Journal article
Kamau A. et al, (2020), BMC Medicine, 18
Trends in health workers’ compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010–2016
Journal article
Amboko B. et al, (2020), Malaria Journal, 19
The relationship between facility-based malaria test positivity rate and community-based parasite prevalence
Journal article
Kamau A. et al, (2020), PLOS ONE, 15, e0240058 - e0240058
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (vol 5, 32, 2020)
Journal article
Pejoski D. et al, (2020), NPJ VACCINES, 5
Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
Journal article
Jao I. et al, (2020), Bioethics, 34, 819 - 832